Macrophage-Derived Biomarkers of Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) is a severe, rapidly progressive diffuse lung disease. Several pathogenetic mechanisms have been hypothesized on the basis of the fibrotic lung damage occurring in this disease, and a potential profibrotic role of activated alveolar macrophages and their mediators...

Full description

Saved in:
Bibliographic Details
Main Authors: E. Bargagli, A. Prasse, C. Olivieri, J. Muller-Quernheim, P. Rottoli
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:Pulmonary Medicine
Online Access:http://dx.doi.org/10.1155/2011/717130
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832556005257379840
author E. Bargagli
A. Prasse
C. Olivieri
J. Muller-Quernheim
P. Rottoli
author_facet E. Bargagli
A. Prasse
C. Olivieri
J. Muller-Quernheim
P. Rottoli
author_sort E. Bargagli
collection DOAJ
description Idiopathic pulmonary fibrosis (IPF) is a severe, rapidly progressive diffuse lung disease. Several pathogenetic mechanisms have been hypothesized on the basis of the fibrotic lung damage occurring in this disease, and a potential profibrotic role of activated alveolar macrophages and their mediators in the pathogenesis of IPF was recently documented. This paper focuses on recent literature on potential biomarkers of IPF derived from activated alveolar macrophages. Biomarker discovery and clinical application are a recent topic of interest in the field of interstitial lung diseases (ILDs). Cytokines, CC-chemokines, and other macrophage-produced mediators are the most promising prognostic biomarkers. Many molecules have been proposed in the literature as potential biomarker of IPF; however, a rigorous validation is needed to confirm their clinical utility.
format Article
id doaj-art-98c5f0bab9ef4dfca117dc1d2d118fa1
institution Kabale University
issn 2090-1836
2090-1844
language English
publishDate 2011-01-01
publisher Wiley
record_format Article
series Pulmonary Medicine
spelling doaj-art-98c5f0bab9ef4dfca117dc1d2d118fa12025-02-03T05:46:40ZengWileyPulmonary Medicine2090-18362090-18442011-01-01201110.1155/2011/717130717130Macrophage-Derived Biomarkers of Idiopathic Pulmonary FibrosisE. Bargagli0A. Prasse1C. Olivieri2J. Muller-Quernheim3P. Rottoli4Respiratory Diseases Section, Siena University, 53100 Siena, ItalyDepartment of Pneumology, Freiburg University, GermanyRespiratory Diseases Section, Siena University, 53100 Siena, ItalyDepartment of Pneumology, Freiburg University, GermanyRespiratory Diseases Section, Siena University, 53100 Siena, ItalyIdiopathic pulmonary fibrosis (IPF) is a severe, rapidly progressive diffuse lung disease. Several pathogenetic mechanisms have been hypothesized on the basis of the fibrotic lung damage occurring in this disease, and a potential profibrotic role of activated alveolar macrophages and their mediators in the pathogenesis of IPF was recently documented. This paper focuses on recent literature on potential biomarkers of IPF derived from activated alveolar macrophages. Biomarker discovery and clinical application are a recent topic of interest in the field of interstitial lung diseases (ILDs). Cytokines, CC-chemokines, and other macrophage-produced mediators are the most promising prognostic biomarkers. Many molecules have been proposed in the literature as potential biomarker of IPF; however, a rigorous validation is needed to confirm their clinical utility.http://dx.doi.org/10.1155/2011/717130
spellingShingle E. Bargagli
A. Prasse
C. Olivieri
J. Muller-Quernheim
P. Rottoli
Macrophage-Derived Biomarkers of Idiopathic Pulmonary Fibrosis
Pulmonary Medicine
title Macrophage-Derived Biomarkers of Idiopathic Pulmonary Fibrosis
title_full Macrophage-Derived Biomarkers of Idiopathic Pulmonary Fibrosis
title_fullStr Macrophage-Derived Biomarkers of Idiopathic Pulmonary Fibrosis
title_full_unstemmed Macrophage-Derived Biomarkers of Idiopathic Pulmonary Fibrosis
title_short Macrophage-Derived Biomarkers of Idiopathic Pulmonary Fibrosis
title_sort macrophage derived biomarkers of idiopathic pulmonary fibrosis
url http://dx.doi.org/10.1155/2011/717130
work_keys_str_mv AT ebargagli macrophagederivedbiomarkersofidiopathicpulmonaryfibrosis
AT aprasse macrophagederivedbiomarkersofidiopathicpulmonaryfibrosis
AT colivieri macrophagederivedbiomarkersofidiopathicpulmonaryfibrosis
AT jmullerquernheim macrophagederivedbiomarkersofidiopathicpulmonaryfibrosis
AT prottoli macrophagederivedbiomarkersofidiopathicpulmonaryfibrosis